Contact
Please use this form to send email to PR contact of this press release:
Albireo Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFIC
TO:
Please use this form to send email to PR contact of this press release:
Albireo Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFIC
TO: